Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 671 for “"AAV"”.
-
Examining the neuroprotective and neurorestorative efficacy of AAV-hGDF5 and AAV-hGDNF in the AAV-αsynuclein rat model of Parkinson’s disease
… brain. The main findings from this thesis were: AAV-delivered GDF5 to the striatum was incapable of protecting against α-synuclein-induced degeneration of the dopaminergic nigrostriatal pathway in adult rats in vivo; delayed administration of either AAV-delivered GDF5 or combination delivery of …
-
Recombinant AAV Gene Therapy and Delivery
… of recombinant adeno-associated viral vector (rAAV) containing both endogenous and synthetic genes for ECE and NEP on amyloid deposition in amyloid precursor protein (APP) plus presenilin-1 (PS1) transgenic mice. rAAV administration directly into the brain resulted in increased expression of ECE …
-
Overcoming Barriers to AAV Gene Transfer
<p> Recombinant adeno-associated virus (AAV) has emerged as a leading platform for therapeutic gene transfer. Despite significant progress and a string of FDA approvals, significant challenges that prevent the broader application of AAV gene therapy exist. High systemic dosing of AAV vectors in the …
-
A Tale Of Two Transgenes: Aav-Dystrophin And Aav-Spike Reveal Common Themes For Gene Therapy And Vaccines
Adeno-associated viruses (AAVs) are non-pathogenic, replication defective viruses that can facilitate long-term gene transfer to a variety of tissues in vivo. However, the limited DNA packaging capacity of AAV (~5 kb) poses challenges for the transfer of large genes. Additionally, while AAV is a …
-
Addressing Aav-Mediated Gene Therapy Challenges In The Retina: Readministration, Aav Capsid Optimization, And In Vitro Disease Modeling
… using recombinant adeno-associated virus (rAAV) and successfully improves visual function in patients diagnosed with Leber’s congenital amaurosis (LCA), a group of severe hereditary retinal degenerations. Despite the success of LuxturnaTM, there remain several challenges to the development …
-
Antiangiogene Gentherapie mittels eines modifizierten AAV-Vektors
… basierend auf Adeno-assoziierten Viren (AAV) für die antiangiogene Gentherapie entwickelt und optimiert. Konventionelle AAV-Vektoren basieren auf einem einzelsträngigen DNA Genom, welches von infizierten Zellen zuerst in ein doppelsträngiges Genom umgewandelt werden muss, um eine …
-
Cross-Species Evolution of New AAV Variants
… and tissues. Recombinant adeno-associated viral (AAV) vectors are a promising delivery platform, but ongoing clinical trials continue to highlight a relatively narrow therapeutic window. Efforts to optimize vector dosing or engineer improved vectors are confounded, at least in part, by differences …
-
Bioverteilungsstudie rekombinanter AAV-Vektoren in der Maus
… zur Tropismusmodifizierung rekombinanter AAV-Vektoren durch Insertion unterschiedlicher Peptide an rezeptorpräsentierenden Stellen.
-
Comprehensive Analysis of the Adeno-Associated Virus (AAV) Transcriptome Based on Next Generation Sequencing Reveals New Insights into AAV Biology
Adeno-associated viruses (AAVs) exhibit a complex biphasic life cycle in cell culture, with productive replication dependent upon co-infection with a helper virus, whereas in the absence of a helper virus AAV latency is established. While vectors based on adeno-associated viruses are already widely …
-
LIVER FIBROSIS IMPAIRS HEPATOCYTE TRANSDUCTION BY AAV VECTORS
Adeno-associated viral vectors (AAVs) are the most promising tools for liver directed gene therapy. However, integrity of hepatic architecture has been considered pre-requisite for efficient gene delivery and clinical studies have been addressed toward patients with no or negligible hepatic damage …
-
Prevalence and characterisation of adeno-associated virus (AAV)
Adeno-associated virus (AAV) is ubiquitous but has not so far been associated with human disease. As a dependovirus, it has a biphasic AAV life cycle with latency phase and helper virus-induced productive replication phase. AAV in vivo persistence requires latency in specialized cell types to …
-
AAV-mediated gene delivery in the cutaneous wound healing
… places a huge burden on the patient and society. AAV is widely used in biological research and is an ideal tool for human gene therapy. But AAV is rarely used in the research of cutaneous wound repair due to several technical issues. Here, we identified that sodium butyrate, a histone deacetylase, …
-
Developing AAV Gene Therapy Tools for Neurodevelopmental Epileptic Encephalopathies
… behavioral and cognitive impairments. AAV gene therapy is a promising approach which could holistically mitigate the disease manifestations by correcting the underlying genetic defect. However, there are several drawbacks that currently restrict their usage. AAVs exhibit limited DNA …
-
Optimizing an AAV-CRISPR system for retinal gene therapy
… retina. We examine several optimizations to the AAV-CRISPR/Cas9 system in vitro in HEK293-eGFP cells. </p> <p><b>Materials and Methods:</b> We compare the effects of sgRNA orientation in both active SaCas9 constructs and deactivated SaCas9 constructs with the KRAB repressor (dSaCas9-KRAB). We …
-
Investigating recombinant AAV (rAAV) gene therapy viral vector production
… vehicles, with the Adeno-Associated Virus (AAV) system the most widely utilised. AAV is a non-enveloped dependovirus with a number of serotypes that can be used to target different tissues; it does not integrate into the genome and has a good safety profile. AAV consists of an icosahedral …
-
Extending the Longevity of AAV-mediated Lung Gene Therapy
AAV-mediated gene therapy has progressed rapidly in the past three decades, permitting the use of this vector for the treatment of several diseases. Although the first administration of an AAV vector into a human patient occurred in 1995 to correct cystic fibrosis in the lungs, this organ remains a …
-
Functional dynamics of the membrane-associated accessory protein (MAAP) during adeno-associated virus (AAV) infection and its implications for recombinant AAV (rAAV) vector production
… proteins of adeno-associated viruses (AAVs); 2) The role of the membrane-associated accessory protein (MAAP) in AAV infection; and 3) Identification of the role of SNARE proteins in recombinant AAV (rAAV) vector production through interaction with the viral MAAP; 4) Conclusion. Chapter …
-
Evaluating Improvements and Challenges in Affinity Chromatography for AAV Purification
… modalities using adeno-associated viruses (AAVs) have been shown to be an effective therapeutic agent for both rare and common diseases in humans. One of the key polishing steps in the downstream manufacturing process of AAVs is affinity chromatography, where a ligand with specific binding …
-
Development of AAV-mediated gene therapy for autosomal recessive bestrophinopathy
… using a recombinant adeno-associated virus (rAAV) has produced positive results in several IRDs. Given the recessive nature of ARB, this thesis proposes that the rAAV-mediated delivery of bestrophin-1 to the RPE could represent a potential therapy. The aims of this thesis were to produce and …
Page 1 of 34